Abstract

Angiotensin‐1‐converting enzyme (ACE), a zinc metallopeptidase, consists of two homologous catalytic domains (N and C) with different substrate specificities. Here we report kinetic parameters of five different forms of human ACE with various amyloid beta (Aβ) substrates together with high resolution crystal structures of the N‐domain in complex with Aβ fragments. For the physiological Aβ(1–16) peptide, a novel ACE cleavage site was found at His14‐Gln15. Furthermore, Aβ(1–16) was preferentially cleaved by the individual N‐domain; however, the presence of an inactive C‐domain in full‐length somatic ACE (sACE) greatly reduced enzyme activity and affected apparent selectivity. Two fluorogenic substrates, Aβ(4–10)Q and Aβ(4–10)Y, underwent endoproteolytic cleavage at the Asp7‐Ser8 bond with all ACE constructs showing greater catalytic efficiency for Aβ(4–10)Y. Surprisingly, in contrast to Aβ(1–16) and Aβ(4–10)Q, sACE showed positive domain cooperativity and the double C‐domain (CC‐sACE) construct no cooperativity towards Aβ(4–10)Y. The structures of the Aβ peptide–ACE complexes revealed a common mode of peptide binding for both domains which principally targets the C‐terminal P2′ position to the S2′ pocket and recognizes the main chain of the P1′ peptide. It is likely that N‐domain selectivity for the amyloid peptide is conferred through the N‐domain specific S2′ residue Thr358. Additionally, the N‐domain can accommodate larger substrates through movement of the N‐terminal helices, as suggested by the disorder of the hinge region in the crystal structures. Our findings are important for the design of domain selective inhibitors as the differences in domain selectivity are more pronounced with the truncated domains compared to the more physiological full‐length forms.DatabaseThe atomic coordinates and structure factors for N‐domain ACE with Aβ peptides 4–10 (5AM8), 10–16 (5AM9), 1–16 (5AMA), 35–42 (5AMB) and (4–10)Y (5AMC) complexes have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ, USA (http://www.rcsb.org/).

Highlights

  • Angiotensin-1-converting enzyme (ACE, EC 3.4.15.1) is a zinc peptidase that plays a pivotal role in the renin-angiotensin-aldosterone system (RAAS) converting angiotensin I to the vasoactive peptide hormone angiotensin II [1,2]

  • Six human angiotensin-1-converting enzyme (ACE) variants were used to examine the molecular mechanism of domain selectivity and interdomain cooperativity towards amyloid beta (Ab) substrates (Fig. 1)

  • Full-length domain knockout variants of somatic ACE (sACE) have had the critical zinc coordinating His residues converted to Lys residues, in the C-domain (N-sACE) and N-domain (C-sACE), inactivating each domain respectively

Read more

Summary

Introduction

Angiotensin-1-converting enzyme (ACE, EC 3.4.15.1) is a zinc peptidase that plays a pivotal role in the renin-angiotensin-aldosterone system (RAAS) converting angiotensin I to the vasoactive peptide hormone angiotensin II [1,2]. In addition to the cleavage of vasopeptides, ACE is able to cleave a variety of peptides that are unrelated to its blood pressure role. While these are perhaps not the most well-known ACE substrates, many have important physiological roles. The N- and C-domains of ACE have been shown to display negative cooperativity in substrate hydrolysis [44,45,46] While this is observed with many synthetic and naturally occurring peptides, not all substrates displayed such an effect [46]. We interrogated the cleavage site specificity of the ACE enzymes and the molecular basis of the Ab peptide binding to the N-domain using high resolution crystal structures of the enzyme in complex with five soluble Ab fragments

Results
Discussion
1.55 I41-A42
Experimental procedures
Conflict of interest
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.